The DOI matches its Crossref record; 501 of the 514 references it cites were found in a registry or an index.
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Open accessAbstract
Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-inducible expression of a battery of genes encoding key components of the glutathione-based and thioredoxin-based antioxidant systems, as well as aldo-keto reductase, glutathione S-transferase, and Nad(p)h quinone oxidoreductase-1 drug-metabolizing isoenzymes along with multidrug-resistance-associated efflux pumps. It therefore plays a pivotal role in both intrinsic resistance and cellular adaptation to reactive oxygen species (ROS) and xenobiotics. Activation of Nrf2 can, however, serve as a double-edged sword because some of the genes it induces may contribute to chemical carcinogenesis by promoting futile redox cycling of polycyclic aromatic hydrocarbon metabolites or confer resistance to chemotherapeutic drugs by increasing the expression of efflux pumps, suggesting its cytoprotective effects will vary in a context-specific fashion. In addition to cytoprotection, Nrf2 also controls genes involved in intermediary metabolism, positively regulating those involved in NADPH generation, purine biosynthesis, and the β-oxidation of fatty acids, while suppressing those involved in lipogenesis and gluconeogenesis. Nrf2 is subject to regulation at multiple levels. Its ability to orchestrate adaptation to oxidants and electrophiles is due principally to stress-stimulated modification of thiols within one of its repressors, the Kelch-like ECH-associated protein 1 (Keap1), which is present in the cullin-3 RING ubiquitin ligase (CRL) complex CRLKeap1. Thus modification of Cys residues in Keap1 blocks CRLKeap1 activity, allowing newly translated Nrf2 to accumulate rapidly and induce its target genes. The ability of Keap1 to repress Nrf2 can be attenuated by p62/sequestosome-1 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent manner, thereby allowing refeeding after fasting to increase Nrf2-target gene expression. In parallel with repression by Keap1, Nrf2 is also repressed by β-transducin repeat-containing protein (β-TrCP), present in the Skp1-cullin-1-F-box protein (SCF) ubiquitin ligase complex SCFβ-TrCP. The ability of SCFβ-TrCP to suppress Nrf2 activity is itself enhanced by prior phosphorylation of the transcription factor by glycogen synthase kinase-3 (GSK-3) through formation of a DSGIS-containing phosphodegron. However, formation of the phosphodegron in Nrf2 by GSK-3 is inhibited by stimuli that activate protein kinase B (PKB)/Akt. In particular, PKB/Akt activity can be increased by phosphoinositide 3-kinase and mTORC2, thereby providing an explanation of why antioxidant-responsive element-driven genes are induced by growth factors and nutrients. Thus Nrf2 activity is tightly controlled via CRLKeap1 and SCFβ-TrCP by oxidative stress and energy-based signals, allowing it to mediate adaptive responses that restore redox homeostasis and modulate intermediary metabolism. Based on the fact that Nrf2 influences multiple biochemical pathways in both positive and negative ways, it is likely its dose-response curve, in terms of susceptibility to certain degenerative disease, is U-shaped. Specifically, too little Nrf2 activity will lead to loss of cytoprotection, diminished antioxidant capacity, and lowered β-oxidation of fatty acids, while conversely also exhibiting heightened sensitivity to ROS-based signaling that involves receptor tyrosine kinases and apoptosis signal-regulating kinase-1. By contrast, too much Nrf2 activity disturbs the homeostatic balance in favor of reduction, and so may have deleterious consequences including overproduction of reduced glutathione and NADPH, the blunting of ROS-based signal transduction, epithelial cell hyperplasia, and failure of certain cell types to differentiate correctly. We discuss the basis of a putative U-shaped Nrf2 dose-response curve in terms of potentially competing processes relevant to different stages of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This interaction is mediated by a 349DPSTGE354 motif in p62’s Keap1-interacting region (KIR) that resembles the ETGE motif in the Keap1-binding domain of Nrf2 [79,80,81].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [79]
In the citing paper
“In response to elevated levels of reactive oxygen species (ROS) and environmental toxins or to nutrient and metabolic changes through mTOR signaling and insulin/IGF signaling, NRF/SKN-1 activates the expression of genes involved in cellular protection (Blackwell et al., 2015; Tebay et al., 2015).”
From The Aging Epigenome (2016) · cites this paper as Tebay et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,897
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,131
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 4,147
Cited by
Sorted by citations
Items 301–400 of 842
The role of ferroptosis in osteoarthritis: Progress and prospects
Sheng, W., Liao, S., Wang, D., Liu, P., & Zeng, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150683 · Cited by 37
Kim, S.-M., Lee, H.-M., Hwang, K., & Choi, K. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.06.048 · Cited by 37
Li, R., Wang, B., Wu, C., Li, D., Wu, Y., Ye, L., Ye, L., Chen, X., Li, P., Yuan, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03407-2 · Cited by 37
Pérez, Ó. C., Barrero, C. A., & Merali, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.770925 · Cited by 36
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
Selvaraju, K., Mofers, A., Pellegrini, P., Salomonsson, J., Ahlner, A., Morad, V., Hillert, E., Espinosa, B., Arnér, E. S. J., Jensen, L. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46168-x · Cited by 35
Armeli, F., Bonucci, A., Maggi, E., Pinto, A., & Businaro, R. (2021) · Biomolecules · doi:10.3390/biom11060790 · Cited by 40
Lekshmi, V. S., Asha, K., Sanicas, M., Asi, A. D., Arya, U. M., & Kumar, B. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1158133 · Cited by 35
NRF2 in age-related musculoskeletal diseases: Role and treatment prospects
Zhang, X., Li, H., Chen, L., Wu, Y., & Li, Y. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.101180 · Cited by 38
Tang, J. S., Vissers, M. C. M., Anderson, R. F., Sreebhavan, S., Bozonet, S. M., Scheepens, A., & Melton, L. D. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700647 · Cited by 35
Li, L., Tian, X., Peng, W., Deng, Y., & Li, J. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.265564 · Cited by 34
Epigenetics/Epigenomics and Prevention of Early Stages of Cancer by Isothiocyanates
Hudlikar, R. R., Wang, L., Wu, R., Li, S. N., Peter, R. M., Shannar, A., Chou, P. J., Liu, X., Liu, Z., Kuo, H. D., et al. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0217 · Cited by 37
NRF2 Regulation by Noncoding RNAs in Cancers: The Present Knowledge and the Way Forward
Fabrizio, F. P., Sparaneo, A., & Muscarella, L. A. (2020) · Cancers · doi:10.3390/cancers12123621 · Cited by 36
Therapeutic potential of Nrf-2 pathway in the treatment of diabetic neuropathy and nephropathy
Gupta, A. K., Behl, T., Sehgal, A., Bhatia, S., Jaglan, D., & BUNGAU, S. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06257-5 · Cited by 37
The Role of Glutathione in Selected Viral Diseases
Wróblewska, J., Wróblewski, M., Hołyńska-Iwan, I., Modrzejewska, M., Nuszkiewicz, J., Wróblewska, W., & Woźniak, A. (2023) · Antioxidants · doi:10.3390/antiox12071325 · Cited by 35
The role of NRF2 transcription factor in inflammatory skin diseases
Salman, S., Paulet, V., Hardonnière, K., & Kerdine‐Römer, S. (2025) · BioFactors · doi:10.1002/biof.70013 · Cited by 43
Chrysanthemum extract attenuates hepatotoxicity via inhibiting oxidative stress in vivo and in vitro
Tian, Z., Jia, H., Jin, Y., Wang, M., Kou, J., Wang, C., Rong, X., Xie, X., Han, G., & Pang, X. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.1667 · Cited by 34
Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability
Nakamura, S., Noguchi, T., Inoue, Y., Sakurai, S., Nishinaka, A., Hida, Y., Masuda, T., Nakagami, Y., Horai, N., Tsusaki, H., et al. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25745 · Cited by 34
Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
Li, C., Zhang, S., Li, L., Hu, Q., & Shen, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.594496 · Cited by 34
Gregorio, J. D., Cilenti, L., Ambivero, C. T., Andl, T., Liao, R., & Zervos, A. S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118963 · Cited by 35
Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer
Wu, J., Xiao, Z., Li, H., Zhu, N., Gu, J., Wang, W., Liu, C., Wang, W., & Li, Q. (2022) · Cancers · doi:10.3390/cancers14143487 · Cited by 34
Mann, G. E., & Forman, H. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.002 · Cited by 34
Li, C., Yan, Y., Shi, Q. W., Kong, Y., Gao, L., Bao, H., & Li, Y. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3273 · Cited by 33
Need (more than) two to Tango: Multiple tools to adapt to changes in oxygen availability
Fratantonio, D., Cimino, F., Speciale, A., & Virgili, F. (2018) · BioFactors · doi:10.1002/biof.1419 · Cited by 34
Parga, J. A., Rodriguez-Perez, A. I., García-Garrote, M., Rodríguez‐Pallares, J., & Labandeira-García, J. L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.409 · Cited by 33
Jin, C., Fu, W., Zhang, D., Xing, W., Xia, W., Wei, Z., Zou, M., Zhu, X., & Xu, D.-G. (2019) · Biomedical Journal · doi:10.1016/j.bj.2018.11.001 · Cited by 33
Sambon, M., Napp, A., Demelenne, A., Vignisse, J., Wins, P., Fillet, M., & Bettendorff, L. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01710 · Cited by 32
Silva‐Islas, C. A., Chánez‐Cárdenas, M. E., Barrera‐Oviedo, D., Ortíz-Plata, A., Pedraza‐Chaverrí, J., & Maldonado, P. D. (2019) · Antioxidants · doi:10.3390/antiox8090410 · Cited by 33
Serapide, M. F., L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Giachino, C., & Marchetti, B. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00024 · Cited by 32
de Araujo, B. P. R., Silva, L., Torresi, J. L. D. B., Siena, A., Valério, B. C. O., Brito, M. D., & Rosenstock, T. R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02059-1 · Cited by 32
Nrf2/HO-1 Axis Regulates the Angiogenesis of Gastric Cancer via Targeting VEGF
Huang, Y., Yang, Y., Xu, Y., Ma, Q., Guo, F., Zhao, Y., Tao, Y., Li, M., & Guo, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s292461 · Cited by 31
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Mukherjee, A. G., & Gopalakrishnan, A. V. (2023) · Medical Oncology · doi:10.1007/s12032-023-02124-4 · Cited by 33
O‐GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2
Zhang, Y., Sun, C., Ma, L., Xiao, G., Gu, Y., & Yu, W. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70037 · Cited by 31
Fragoulis, A., Schenkel, J., Herzog, M., Schellenberg, T., Jahr, H., Pufe, T., Trautwein, C., Kensler, T. W., Streetz, K. L., & Wruck, C. J. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz055 · Cited by 32
Abokyi, S., Shan, S. W., To, C. H., Chan, H. H., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5296341 · Cited by 32
Iskandar, A. R., Martin, F. P., Leroy, P., Schlage, W. K., Mathis, C., Titz, B., Kondylis, A., Schneider, T. L., Vuillaume, G., Sewer, A., et al. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.063 · Cited by 32
Cai, F., Li, D., Zhou, K., Zhang, W., & Yang, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155407 · Cited by 35
Interactions between zinc and NRF2 in vascular redox signalling
Yang, F., Smith, M. J., Siow, R. C. M., Aarsland, D., Maret, W., & Mann, G. E. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230490 · Cited by 32
Patibandla, C., van Aalten, L., Dinkova‐Kostova, A. T., Honda, T., Cuadrado, A., Fernández-Ginés, R., McNeilly, A. D., Hayes, J. D., Cantley, J., & Sutherland, C. D. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103117 · Cited by 32
Self-citationMetabolic Responses in Endothelial Cells Following Exposure to Ketone Bodies
Meroni, E., Papini, N., Criscuoli, F., Casiraghi, M. C., Massaccesi, L., Basilico, N., & Erba, D. (2018) · Nutrients · doi:10.3390/nu10020250 · Cited by 31
Martin-Rincon, M., Gelabert-Rebato, M., Galvan-Alvarez, V., Gallego-Selles, A., Martinez-Canton, M., Lopez-Rios, L., Wiebe, J. C., Martin-Rodriguez, S., Arteaga-Ortiz, R., Dorado, C., et al. (2020) · Nutrients · doi:10.3390/nu12030614 · Cited by 31
Protective Effects of Cannabidiol on the Membrane Proteome of UVB-Irradiated Keratinocytes
Atalay, S., Gęgotek, A., & Skrzydlewska, E. (2021) · Antioxidants · doi:10.3390/antiox10030402 · Cited by 32
Armand, L., Fofana, M., Couturier-Becavin, K., Andriamihaja, M., & Blachier, F. (2022) · Amino Acids · doi:10.1007/s00726-021-03122-4 · Cited by 33
Bartolini, D., Arato, I., Mancuso, F., Giustarini, D., Bellucci, C., Vacca, C., Aglietti, M. C., Stabile, A. M., Rossi, R., Cruciani, G., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12806 · Cited by 31
Keap1–Nrf2 regulated redox signaling in utero: Priming of disease susceptibility in offspring
Chapple, S. J., Puszyk, W. M., & Mann, G. E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.001 · Cited by 31
Sharma, S. H., Rajamanickam, V., & Nagarajan, S. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000496 · Cited by 32
Yu, Y., Yang, A., Yu, G., & Wang, H. (2022) · Biomolecules · doi:10.3390/biom12111637 · Cited by 33
Baird, L., & Yamamoto, M. P. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102904 · Cited by 31
NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma
Cirotti, C., Taddei, I., Contadini, C., Girolamo, C. D., Pepe, G., Bardi, M. D., Borsellino, G., Helmer‐Citterich, M., & Barilà, D. (2023) · Life Science Alliance · doi:10.26508/lsa.202302205 · Cited by 31
Tong, J., Shu, J., Wang, Y., Qi, Y., & Wang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122904 · Cited by 30
Multiple functions of the histone chaperone Jun dimerization protein 2
Tsai, M.-H., Wuputra, K., Lin, Y., Lin, C., & Yokoyama, K. K. (2016) · Gene · doi:10.1016/j.gene.2016.03.048 · Cited by 30
Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Speciale, A., Saija, A., Bashllari, R., Molonia, M. S., Muscarà, C., Occhiuto, C., Cimino, F., & Cristani, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181112093336 · Cited by 31
Lekshmi, V. S., Rauf, A. A., & Kurup, G. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.05.044 · Cited by 30
Wu, B., Yue, H., Zhou, G. H., Zhu, Y. Y., Wu, T. H., Wen, J. F., Cho, K. W., & Jin, S. N. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172717 · Cited by 30
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30
Approaching reactive species in the frame of their clinical significance: A toxicological appraisal
Veskoukis, A. S., Tsatsakis, A. M., & Kouretas, D. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111206 · Cited by 33
Fasting Drives Nrf2-Related Antioxidant Response in Skeletal Muscle
Lettieri‐Barbato, D., Minopoli, G., Caggiano, R., Izzo, R., Santillo, M., Aquilano, K., & Faraonio, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207780 · Cited by 29
Meeran, M. F. N., Laham, F., Azimullah, S., Sharma, C., Kaabi, A. A., Tariq, S., Adeghate, E. A., Goyal, S. N., & Ojha, S. K. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.046 · Cited by 31
Chen, F., Zhu, J., & Wang, W. (2021) · Inflammation · doi:10.1007/s10753-021-01505-z · Cited by 30
Hormone-linked redox status and its modulation by antioxidants
Sahoo, D. K., & Chainy, G. B. N. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2022.10.007 · Cited by 34
Activation of the Keap1/Nrf2 stress response pathway in autophagic vacuolar myopathies
Duleh, S., Wang, X., Komirenko, A., & Margeta, M. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0384-6 · Cited by 32
Apweiler, M., Saliba, S. W., Sun, L., Streyczek, J., Normann, C., Hellwig, S., Bräse, S., & Fiebich, B. L. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02614-5 · Cited by 31
Epigenetic Control of NRF2-Directed Cellular Antioxidant Status in Dictating Life-Death Decisions
Hayes, J. D., & Dinkova‐Kostova, A. T. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.023 · Cited by 29
Self-citationPruimboom, L., & Muskiet, F. A. J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.08.002 · Cited by 33
Pharmacology of ME-344, a novel cytotoxic isoflavone
Zhang, L., Zhang, J., Ye, Z., Townsend, D. M., & Tew, K. D. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.01.005 · Cited by 30
Zhao, H., Li, H., Feng, Y., Zhang, Y., Yuan, F., Zhang, J., Ren, H., & Jia, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194872 · Cited by 29
Yang, H., Xiang, S., Kazi, A., & Sebti, S. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011930 · Cited by 29
A polyphenol rich sugarcane extract as a modulator for inflammation and neurological disorders
Ji, J., Flavel, M., Yang, X., Chen, O. C. Y., Downey, L. A., Stough, C. K. K., & Kitchen, B. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100187 · Cited by 31
Targeted de-repression of neuronal Nrf2 inhibits α-synuclein accumulation
Baxter, P. S., Márkus, N. M., Dando, O., He, X., Al-Mubarak, B. R., Qiu, J., & Hardingham, G. E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03507-z · Cited by 31
Galli, F., Marcantonini, G., Giustarini, D., Albertini, M. C., Migni, A., Zatini, L., Gioiello, A., Rossi, R., & Bartolini, D. (2022) · Antioxidants · doi:10.3390/antiox11071366 · Cited by 29
Bartolini, D., Giustarini, D., Pietrella, D., Rossi, R., & Galli, F. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09517-5 · Cited by 28
Zinc and the modulation of Nrf2 in human neuroblastoma cells
Kaufman, Z., Salvador, G. A., Liu, X., & Oteiza, P. I. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.010 · Cited by 30
The pharmacological basis of the curcumin nutraceutical uses: an update
Canistro, D., Chiavaroli, A., Cicia, D., Cimino, F., Currò, D., Agli, M. D., Ferrante, C., Giovannelli, L., Leone, S., Martinelli, G., et al. (2021) · doi:10.36118/pharmadvances.2021.06 · Cited by 28
Emami, M. H., Sereshki, N., Malakoutikhah, Z., Dehkordi, S. A. E., Fahim, A., Mohammadzadeh, S., & Maghool, F. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109266 · Cited by 30
Identification of Non-Electrophilic Nrf2 Activators from Approved Drugs
Zhang, Q., Chu, X., Jiang, L.-H., Liu, M., Mei, Z., & Zhang, H. (2017) · Molecules · doi:10.3390/molecules22060883 · Cited by 28
Munguía-Martínez, M. F., Nava-Ruíz, C., Ruíz-Díaz, A., Dı́az-Ruiz, A., Yescas, P., & Méndez‐Armenta, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1327986 · Cited by 28
Li, X., Huo, C., Yuan, X. H., Xu, R., Liu, Y., Jia, X., & Wang, X. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00222 · Cited by 28
Arachchige, D. L., Dwivedi, S. K., Jaeger, S., Olowolagba, A. M., Mahmoud, M. E., Tucker, D. R., Fritz, D. R., Werner, T., Tanasova, M., Luck, R. L., et al. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00320 · Cited by 27
Martinez‐Canton, M., Galván-Álvarez, V., Martín-Rincón, M., Calbet, J. A. L., & Gallego-Selles, Á. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.08.011 · Cited by 29
Kaitsuka, T., & Hakim, F. (2021) · Biology · doi:10.3390/biology10020084 · Cited by 27
Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension
Rafikov, R., Nair, V., Sinari, S. A., Babu, H., Sullivan, J. C., Yuan, J. X. ‐., Desai, A. A., & Rafikova, O. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7664 · Cited by 27
Neitzel, C., Seiwert, N., Göder, A., Diehl, E., Weber, C., Nagel, G., Stroh, S., Rasenberger, B., Christmann, M., & Fahrer, J. (2019) · Cells · doi:10.3390/cells8080794 · Cited by 27
Shilovsky, G. A., & Dibrova, D. V. (2023) · Life · doi:10.3390/life13041045 · Cited by 27
Gan, L., Wang, W., Jiang, J., Tian, K., Liu, W., & Cao, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429836 · Cited by 29
Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases
Wang, T., Liu, M., Li, X., Zhang, S., Gu, H., Wei, X., Wang, X., Xu, Z., & Shen, T. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.035 · Cited by 29
Wang, K.-C., Liu, Y., El‐Shazly, M., Shih, S., Du, Y.-C., Hsu, Y., Lin, H., Chen, Y., Wu, Y., Yang, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081935 · Cited by 26
Lü, X., Zhang, Q., Xu, L., Xiuying, L., Fu, J., Wang, X., Liu, Y., Lin, Y., Li, B., Wang, R., et al. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00152.2019 · Cited by 26
Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
Jiménez-Moreno, N., & Lane, J. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8865611 · Cited by 26
Wang, L., Lavier, J., Hua, W., Wang, Y., Gong, L., Hao, W., Wang, J., Pellegrin, M., Millet, G. P., & Zhang, Y. (2021) · Antioxidants · doi:10.3390/antiox10070992 · Cited by 26
Ishii, T., Warabi, E., & Mann, G. E. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102103 · Cited by 28
Involvement of antioxidant enzymes in Parkinson’s disease
Tahavvori, A., Gargari, M. K., Yazdani, Y., Mamalo, A. S., Beilankouhi, E. A. V., & Valilo, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154757 · Cited by 28
Cuadrado, A., Cazalla, E., Bach, A., Bathish, B., Naidu, S. D., DeNicola, G. M., Dinkova-Kostova, A. T., Fernández-Ginés, R., Grochot-Przeczek, A., Hayes, J. D., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103569 · Cited by 28
Self-citationAndrés, C. M. C., Lobo, F., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Lebeña, E. P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090765 · Cited by 28
Amyloid-β 25-35 Induces Neurotoxicity through the Up-Regulation of Astrocytic System Xc−
D’Ezio, V., Colasanti, M., & Persichini, T. (2021) · Antioxidants · doi:10.3390/antiox10111685 · Cited by 26
Nrf2/ARE axis signalling in hepatocyte cellular death
Ghanim, B. Y., & Qinna, N. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07125-6 · Cited by 32
Shilovsky, G. A. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922010060 · Cited by 24
Alshammari, G. M., Abdelhalim, M. A. K., Al-Ayed, M. S., Al‐Harbi, L. N., & Yahya, M. A. (2022) · Nutrients · doi:10.3390/nu14163327 · Cited by 25
Deng, Y., Xiao, W., Chen, L., Liu, Q., Liu, Z., & Gong, Z. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.04.029 · Cited by 25
NRF2 negatively regulates primary ciliogenesis and hedgehog signaling
Liu, P., Dodson, M. B., Fang, D., Chapman, E., & Zhang, D. D. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000620 · Cited by 25
Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review
Carvalho, A. A. D. S. (2020) · Current Pharmacology Reports · doi:10.1007/s40495-020-00243-4 · Cited by 26
Genetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2
Zazueta, C., Jiménez‐Uribe, A. P., Pedraza‐Chaverrí, J., & Buelna‐Chontal, M. (2022) · Antioxidants · doi:10.3390/antiox11030507 · Cited by 27
Metadata
- Authors
- Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D.
- Affiliations
- University of Dundee (GB)
- AstraZeneca (United Kingdom) (GB)
- University of Pennsylvania (US)
- Corresponding author
- Hayes, John D.
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- Pt B
- Pages
- 108-146
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC4659505
- OpenAlex
- W1421415727
- Cited by
- 837
- References
- 514
- Citations by year
- 2026: 56 · 2025: 54 · 2024: 65 · 2023: 89 · 2022: 90 · 2021: 92 · 2020: 103 · 2019: 88 · 2018: 72 · 2017: 75 · 2016: 45 · 2015: 7
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Cancer Research UK (C4909/A13786)
- MRC (MR/J001465/1)
- MRC ITTP (1313992)
- BBSRC Industrial CASE (BB/L01405X/1)
- BBSRC (BB/L01923X/1, P30-ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, redox stress, Keap1, mTORC1, p62/sequestosome 1, nutrient sensing, energy status, reactive oxygen species, xenobiotic metabolism, drug resistance, multidrug resistance, glutathione, thioredoxin, antioxidant defense, degenerative diseases
- MeSH terms
- Animals, Humans, Oxidation-Reduction, Signal Transduction, Oxidative Stress, NF-E2-Related Factor 2, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
